Article
Understanding the genetic aspects of resistance to antidepressants treatment.
European review for medical and pharmacological sciences - 1 Jul 2020
Alqahtani A M, Kumarappan C, Kumar V, Srinivasan R, Krishnaraju V
Abstract excerpt
Major depression disorder (MDD) is an extremely prevalent disorder and is expected to be the second leading cause of disease burden by 2020 according to the World Health Organisation (WHO). Moreover, this disease burden is predicted to rise in the next 20 years. Antidepressant medications are vital in the therapy of major depression. However, approximately 30-60% of patients treated with current antidepressant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.